SCHEMBL20744755

SCHEMBL20744755

Nc1ncnc2c1c(Br)nn2[C@H]1C[C@H](OCc2ccccc2)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 4/20 0.45
▸ JAK3 P52333 4/20 0.45
▸ JAK1 P23458 3/20 0.44
▸ RET P07949 2/20 0.42
▸ BTK Q06187 4/20 0.42
▸ LCK P06239 1/20 0.42
▸ LYN P07948 1/20 0.42
▸ ADK P55263 3/20 0.42
▸ PIK3CD O00329 2/20 0.41
▸ PIK3CA P42336 1/20 0.41
▸ PIK3CB P42338 1/20 0.41
▸ PIK3CG P48736 1/20 0.41
▸ PRKDC P78527 1/20 0.41
▸ IGF1R P08069 4/20 0.40
▸ EGFR P00533 2/20 0.40
▸ ATR Q13535 1/20 0.40
▸ NUDT14 O95848 1/20 0.40
▸ NUDT5 Q9UKK9 1/20 0.40
▸ FYN P06241 1/20 0.40
▸ MAP2K5 Q13163 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20754371 1.00 JAK2 (0.45) JAK2JAK3JAK1RETBTK
SCHEMBL24096712 0.88 RET (0.45) RETBTKLCKLYNPIK3CD
SCHEMBL20746345 0.87 RET (0.44) RETBTKLCKLYNPIK3CD
SCHEMBL30321048 0.87 RET (0.52) JAK2JAK3RETBTKLCK
SCHEMBL24096711 0.87 RET (0.52) JAK2JAK3RETBTKLCK
SCHEMBL22944055 0.87 RET (0.44) RETBTKLCKLYNPIK3CD
SCHEMBL20744806 0.84 RET (0.43) RETBTKLCKLYNPIK3CD
SCHEMBL20744804 0.84 RET (0.43) RETBTKLCKLYNPIK3CD
SCHEMBL20754240 0.84 BTK (0.44) JAK3RETBTKLCKLYN
SCHEMBL24005941 0.83 ATG7 (0.48) RETBTKLCKLYNPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3668875-A1 CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO Vyera Pharmaceuticals, LLC (US) 2020-06-24 — — EP disclosed
WO-2019036001-A1 CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO Vyera Pharmaceuticals, LLC (US) 2019-02-21 — — WO disclosed
Send feedback